Dalian Chemphy Chemical Co.,Ltd., located in the Songmu Island Chemical Industry Park of Puwan New Area, Dalian City, Liaoning Province, is a national high-tech enterprise specializing in the research, development, production, and sales of high-end specialty chemicals. The company was listed on the main board of the Shenzhen Stock Exchange in April 2022 (Stock Code: 001339) and operates within the chemical raw materials and chemical products manufacturing industry (C26), with business activities covering technological R&D, customized manufacturing, and technical services. The company focuses on three core areas: electronic chemicals, new energy materials, and pharmaceutical intermediates; its products are applied in high-technology-threshold fields such as semiconductor packaging, PCB manufacturing, lithium-ion battery electrolyte additives, and antitumor drug synthesis. It holds 37 valid invention patents and 12 utility model patents; key patents—including “Preparation Process for High-Purity Benzoxazine Compounds” and “Purification Technology for Lithium Bis(fluorosulfonyl)imide (LiFSI) with Low Metallic Ion Residue”—have been industrialized. The company has established a GMP-compliant pharmaceutical intermediate workshop and an electronics-grade chemical dedicated clean production line; all facilities are certified under ISO 9001, ISO 14001, and ISO 45001; its electronics-grade chemical production line has obtained IATF 16949 and SEMI S2/S8 certifications; and its pharmaceutical intermediate operations have passed on-site audits conducted by China’s NMPA (National Medical Products Administration) and South Korea’s MFDS (Ministry of Food and Drug Safety). In 2024, revenue from electronic chemicals accounted for 41.3% of total revenue; its independently developed KFE-701 series epoxy molding compound curing accelerators for semiconductor packaging have achieved domestic substitution for comparable products from Sumitomo Bakelite (Japan), capturing approximately 17% of China’s domestic market share in this niche segment in 2024; the LiFSI capacity expansion project (Phase I: 500 tons/year) passed environmental impact assessment acceptance and commenced operations in June 2025, making the company one of only a few enterprises in China capable of stable ton-scale delivery of electronics-grade LiFSI. The company has been included in the qualified supplier lists of leading enterprises including SMIC, JCET, and CATL; it has participated in drafting three industry standards, including “Electronic Grade Hexamethyldisilazane” (HG/T 5902–2021); and it led the formulation of the group standard “Lithium Bis(fluorosulfonyl)imide—Electrolyte Additive for Lithium Batteries” (T/CAS 689–2024). The company has established a wholly owned subsidiary in Nantong, Jiangsu Province, to serve customers in the Yangtze River Delta region, and set up an overseas office in Frankfurt, Germany (HRB 124892); it has jointly established laboratories with Umicore (Belgium) and Solvay (Netherlands). In 2025, export revenue accounted for 22.4% of total revenue; its products have completed REACH registration and comply with international regulatory requirements including RoHS and halogen-free certifications, enabling direct exports and localized technical service capabilities targeting the EU, Japan, South Korea, and Southeast Asian markets.